#  Marc Isaac Damelin 

2002 PhD Graduate in Biophysics

Chief Scientific Officer at Alphina Therapeutics

 

 

 



   ![Photo of Dr. Marc Damelin](/sites/g/files/omnuum9451/files/styles/hwp_4_5__480x600/public/2026-06/Damelin%20headshot.jpg?itok=UOGej8Ob) 

 



 

 laptop\_windows [Dr. Marc Damelin LinkedIn Page](http://www.linkedin.com/in/marcdamelin) 

 

 



 

**Dissertation Title:** Analysis of Nuclear Organization: Nucleocytoplasmic Transport and Chromatin Remodeling

**PhD Dissertation Advisor:** Dr. Pamela A. Silver, Dept. of Biological Chemistry & Molecular Pharmacology, Dana-Farber Cancer Institute/ Harvard Medical School

Marc has been in the biopharma industry since 2007, following a postdoctoral fellowship with the Damon Runyon Cancer Research Foundation. His industry work has focused on developing antibody-drug conjugates (ADC) for oncology, with experience in big pharma as well as biotech.



 

 

 





 

 

- ## Alumni Alphabetical
    
     [Alumni A-E](/alumni-alphabetical/alumni-e)
- ## People Terms
    
     [Alumni/ Graduated Students](/people-terms/alumni-graduated-students) [2002 Biophysics Graduates](/people-terms/2002-biophysics-graduates)